AUG 22, 2018 6:25 AM PDT

Testing For Cognitive Decline Made Easier

In any form of disease, the sooner a diagnosis is found, the sooner treatment can begin.

Finding a health problem early is the best way to increase the chances of a good outcome. This is especially true in cognitive impairment. Whether it’s normal age-related memory issues, or something more severe, like Alzheimer’s, knowing where a patient is, cognitively, is crucial.

Diagnostic tests like looking for biomarkers in the blood are not available for most cases of dementia. Alzheimer’s has no definitive test that can say with the same certainty as an X-ray or other assays that there is a problem. Many patients must go through complex neuropsychological testing and detailed questionnaires on their health and habits. These kinds of tests are time-consuming and can be expensive as well. They are not entirely objective either, because confounding factors like IQ, socioeconomic status, and environmental factors such as places of residence. Estimates from the WHO and the CDC have shown that globally, the number of older adults that will develop dementia is growing every year. Right now about 50 million people worldwide are living with some form of cognitive decline, so anything that aids in early detection is vital.

A team of researchers from the UK and Switzerland has developed a remarkably simple assessment that their study suggests could help improve the process of early diagnosis of mild cognitive impairment (MCI.) About 30 to 50 percent of patients with MCI will go on to develop Alzheimer’s so a test that can measure impairment would be useful in helping patients and their caregivers set up early interventions like therapy, activities, or diet changes to stay as healthy as possible for as long as possible.

The research included UK researchers Dr. Trudi Edginton from City, University of London and Dr. Alison Eardley from the University of Westminster and was led by Professor Micah Murray from the University of Lausanne, Switzerland. It was published in the journal Scientific Reports. The cohort was 123 participants. Of the group, 51 were healthy young adults, 49 were healthy older adults, and the remaining 23 were older adults with a diagnosis of MCI. What they were asked to do was quite simple, but provided results the scientists say were valuable. Volunteers were asked to push a button whenever they hear a sound or see a light flash. The sounds and lights were visible on a laptop screen, but the team says that it’s possible that an app for a smartphone or tablet could come out of the work.

The patients in the study had to indicate when they heard just a sound, saw just a light or when they noticed both at the same time. The speed at which they indicated what they had seen or heard was measured. Cognition is often assessed via the sense of hearing or vision, so the test, while simple, can show quite a bit about a patient’s mental acuity. Using just the two measurements of whether they were faster at detecting light or sound and how fast they were able to detect a combination of both, the researchers say they were able to tell which had MCI and which did not accurately.

Professor Murray explained the work, stating “We are particularly excited about this work because it shows how very simple tests can help clinical practice by reaching a wider population, at a lower cost. We are happy that our findings clarify the link between our vision and hearing and their role in supporting memory (dys-)function; it becomes increasingly clear that how preserved our cognitive skills are as we age depends on how intact our senses are. This importantly extends our similar existing findings in school-age children.”

The clip below talks about cognitive impairment and some of the signs to look for, check it out.

Sources: City, University of London, Nature, Scientific Reports New Atlas

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
JUL 07, 2021
Cannabis Sciences
Experts Reach Consensus on Dosing Cannabis for Chronic Pain
JUL 07, 2021
Experts Reach Consensus on Dosing Cannabis for Chronic Pain
Twenty cannabis experts from across the globe have reached a consensus on how medical cannabis may be used to treat chro ...
AUG 15, 2021
Drug Discovery & Development
Diabetes Drug May Reduce Alzheimer's Risk
AUG 15, 2021
Diabetes Drug May Reduce Alzheimer's Risk
People who take a drug used to lower blood sugar levels in type 2 diabetes have less amyloid-beta in their brains, a bio ...
AUG 16, 2021
Neuroscience
My Mind's a Blank! How Sleep-Like States Occur During Wakefulness
AUG 16, 2021
My Mind's a Blank! How Sleep-Like States Occur During Wakefulness
Researchers identify neural mechanism common to both attention lapses and sleeping.
SEP 03, 2021
Technology
Bionic Arm Effective at Restoring "Natural" Arm Function in Amputees
SEP 03, 2021
Bionic Arm Effective at Restoring "Natural" Arm Function in Amputees
A research team at the Cleveland Clinic has developed a new mechanical arm that could help people who have received arm ...
SEP 07, 2021
Cell & Molecular Biology
Genetic Influences That Help Make the Human Brain Unique
SEP 07, 2021
Genetic Influences That Help Make the Human Brain Unique
For years, many researchers have been trying to answer the question "What makes us human?" from both a biological and ph ...
SEP 07, 2021
Health & Medicine
Vaccines- a Long History of Cost-Benefit Analysis
SEP 07, 2021
Vaccines- a Long History of Cost-Benefit Analysis
Vaccination and new treatments for diseases have remained topics of skepticism since their inception. When it came to an ...
Loading Comments...